New Delhi: Alembic Pharmaceuticals Ltd on Thursday said it has received tentative approval from the US health regulator for its generic version of Darolutamide tablets indicated for treatment of ...

Alembic Pharmaceuticals Ltd on Monday said it has received tentative approval from the US health regulator for its Bosutinib tablets used in the treatment of certain types of cancer. The tentative ...

Alembic Pharmaceuticals Share Price | The tablets are indicated for the management of chronic stable angina and angina due to coronary artery spasm. Alembic Pharmaceuticals share price rose 2 percent ...

Alembic Technologies has raised $145 million in Series B and growth funding at a valuation 15 times higher than its previous round, betting that the next competitive advantage in artificial ...

Software engineer. Primary focus - Python & mathematics. Designing API servers and pipelines. Following my previous post about setting a function-level database setup, which is a junior-level solution ...

Alembic Pharmaceuticals Limited has announced that it has received approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Ticagrelor Tablets, 60 mg.

Alembic Pharmaceuticals shares rose 2.3 per cent on Tuesday, August 19, 2025, logging an intra-day high at ₹996.15 per share on BSE. At 11:29 AM, Alembic Pharmaceuticals share price was trading 1.88 ...

Pivya has been proven safe in three studies. Credit: Summit Art Creations/Shutterstock. Alembic Pharmaceuticals has acquired UTILITY therapeutics, expanding its portfolio with the addition of Pivya ...

Nlembic Pharmaceuticals I nc., the US subsidiary of Alembic Pharmaceuticals, has acquired Utility Therapeutics Ltd in a $12 million deal to strengthen its presence in the US market. Alembic will begin ...

Alembic Pharmaceuticals share price: Pharmaceuticals company Alembic Pharmaceuticals shares were trading higher on Thursday, July 3, 2025, with the scrip rising up to 2.05 per cent to hit an intraday ...